Rampart

Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team

Retrieved on: 
Tuesday, October 24, 2023

Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.

Key Points: 
  • Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.
  • The new financing builds on an initial $40 million seed investment from OrbiMed.
  • The Rampart team has tremendous heart and a fierce commitment to reshaping the treatment landscape for those in dire need of better options,” said Louis Breton, Rampart Co-founder, Chief Executive Officer, and Board Director.
  • “Rampart’s DNA medicines contain novel structural elements that drive nuclear trafficking and retention while avoiding immune responses,” said Jeffrey Bartlett, Ph.D., Rampart Co-founder and Chief Innovation and Technical Officer.

RAMPART IC Announces the Addition of Rob Williamson to Its Board of Managers

Retrieved on: 
Saturday, September 2, 2023

BIRMINGHAM, Ala., Sept. 2, 2023 /PRNewswire-PRWeb/ -- RAMPART IC has named Rob Williamson to its Board of Managers. Rob has spent the last 25 years in the medical devices industry, with companies such as Medtronic, Covidien, ev3, FoxHollow, and Bard. Most recently Rob served as the vice president of sales for Shockwave Medical where he built a sales team of more than 300 field reps and achieved more than $500M in revenue. Rob brings a wealth of start-up, commercial, and board experience to Rampart IC.

Key Points: 
  • BIRMINGHAM, Ala., Sept. 2, 2023 /PRNewswire-PRWeb/ -- RAMPART IC has named Rob Williamson to its Board of Managers.
  • "The Rampart team is excited and honored to have Rob join our Board of Managers and leadership team," said Rampart President and CEO Tom Livingston.
  • "The Rampart team is excited and honored to have Rob join our Board of Managers and leadership team," said Rampart President and CEO Tom Livingston.
  • "The Rampart team is excited and honored to have Rob join our Board of Managers and leadership team," said Rampart President and CEO Tom Livingston.

Rampart IC Announces Collaboration With Boston Scientific Corporation to Expand Access to Radiation Safety and Orthopedic Protection

Retrieved on: 
Wednesday, February 22, 2023

BIRMINGHAM, Ala., Feb. 22, 2023 /PRNewswire-PRWeb/ -- Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, announced a collaborative agreement with Boston Scientific Corporation, a leading medical device manufacturer, to expand access and promote the importance of radiation safety and orthopedic protection solutions to medical professionals. The companies will work together on sales program offerings for physicians who could benefit from the Rampart shielding technology.

Key Points: 
  • Rampart IC, a Birmingham, Alabama -based medical device company specializing in radiation shielding and orthopedic protection, today announced a collaborative agreement with Boston Scientific Corporation, a leading medical device manufacturer, to expand access and promote the importance of radiation safety and orthopedic protection solutions to medical professionals.
  • BIRMINGHAM, Ala., Feb. 22, 2023 /PRNewswire-PRWeb/ -- Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, announced a collaborative agreement with Boston Scientific Corporation, a leading medical device manufacturer, to expand access and promote the importance of radiation safety and orthopedic protection solutions to medical professionals.
  • "We are honored to work with Boston Scientific, a global medical technology leader, to address a significant unmet need through the protection of more cath lab professionals from harmful radiation exposure," said Tom Livingston, Rampart IC President and CEO.
  • The Rampart IC system is already employed by several prominent American healthcare systems and prestigious university medical institutions.

Patricia L. Blake is recognized by Continental Who's Who

Retrieved on: 
Tuesday, February 21, 2023

YERINGTON, Nev., Feb. 21, 2023 /PRNewswire/ -- Patricia L. Blake is being recognized by Continental Who's Who as a Distinguished Professional for her contributions as a community servant as a Retired Police Lieutenant and Author.

Key Points: 
  • YERINGTON, Nev., Feb. 21, 2023 /PRNewswire/ -- Patricia L. Blake is being recognized by Continental Who's Who as a Distinguished Professional for her contributions as a community servant as a Retired Police Lieutenant and Author.
  • Officer Blake was recognized for her exceptional leadership and mentoring during her career with the department in 2014.
  • Officer Blake joined the Los Angeles Police Department (LAPD) in May of 1983 and served for almost 34 years.
  • For more information on Patricia L. Blake, her Instagram handle is @authorpatricialblake.

Rampart IC Expands its International Distribution Network

Retrieved on: 
Thursday, December 1, 2022

BIRMINGHAM, Ala., Dec. 1, 2022 /PRNewswire-PRWeb/ -- Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, has signed five distribution agreements that expand their distribution throughout the Middle East, Asia, Europe and North America.

Key Points: 
  • Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, has signed five distribution agreements that expand their distribution throughout the Middle East, Asia, Europe and North America.
  • BIRMINGHAM, Ala., Dec. 1, 2022 /PRNewswire-PRWeb/ -- Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, has signed five distribution agreements that expand their distribution throughout the Middle East, Asia, Europe and North America.
  • Rampart IC has existing distribution agreements in place with med tech distributors serving medical facilities throughout Europe, Australia and New Zealand, and Japan.
  • "Rampart's global mission is to protect as many interventional teams as possible," said Tom Livingston, Rampart IC Chief Executive Officer.

Doyon, Limited and Alaska Communications Will Bring Affordable, High-Speed Broadband to Five Tribal Communities in Alaska

Retrieved on: 
Monday, August 8, 2022

Alaska Communications will deploy a fiber-to-the-home network in each community, offering up to Gigabit speed service at affordable rates.

Key Points: 
  • Alaska Communications will deploy a fiber-to-the-home network in each community, offering up to Gigabit speed service at affordable rates.
  • The network will connect to the Alaska Communications core fiber network in Fairbanks, Alaska.
  • The project is part of the Alaska FiberOptic Project, a larger collaboration between Calista Corporation, Doyon, Limited, Gana-A Yoo Limited and Alaska Communications to connect up to 20 communities along the Yukon and Kuskokwim Rivers with fiber-optic cable.
  • Alaska Communications, a subsidiary of ATN International, Inc. (NASDAQ: ATNI), is the leading provider of advanced broadband and managed IT services for businesses and consumers in Alaska.

RAMPART Announces Acquisition of Xion(R) Protective Gear's PPE Division

Retrieved on: 
Friday, April 8, 2022

Ottawa, Ontario--(Newsfile Corp. - April 8, 2022) - RAMPART International Corp, a leading supplier of operational equipment to Law Enforcement and Military end users, is proud to announce the completed acquisition of the Xion Protective Gear PPE line from Xion Protective Gear.

Key Points: 
  • Ottawa, Ontario--(Newsfile Corp. - April 8, 2022) - RAMPART International Corp, a leading supplier of operational equipment to Law Enforcement and Military end users, is proud to announce the completed acquisition of the Xion Protective Gear PPE line from Xion Protective Gear.
  • Their PPE line of protective base layers can be worn comfortably underneath any uniform or workwear and will protect the user from blunt trauma impact through impact protection technology from D3O.
  • While the acquisition is a new change, Rampart and Xion Protective Gear PPE have had a long-standing relationship.
  • Going forward Xion Protective Gear PPE will operate singularly under the Rampart company.

Rampart IC Announces Distribution to Japan

Retrieved on: 
Wednesday, March 9, 2022

BIRMINGHAM, Ala., March 9, 2022 /PRNewswire-PRWeb/ -- Rampart IC, a medical device company specializing in radiation shielding and orthopedic protection, has signed an exclusive distribution agreement with Japan Lifeline (JLL), securing distribution to the Japanese market.

Key Points: 
  • BIRMINGHAM, Ala., March 9, 2022 /PRNewswire-PRWeb/ -- Rampart IC, a medical device company specializing in radiation shielding and orthopedic protection, has signed an exclusive distribution agreement with Japan Lifeline (JLL), securing distribution to the Japanese market.
  • The Rampart M1128 is a device developed for interventional cardiologists (ICs), but has found its way into several interventional specialties.
  • Our global partners are facilitating adoption of Rampart because it is a solution for a universal problem," said Tom Livingston, Rampart IC Chief Executive Officer.
  • The Rampart IC system is in use with American healthcare systems including Ascension, Sutter Health and Northwell.